Important steps toward streamlining access to investigational drugs for patients in need

By: Richard A. Moscicki, M.D. FDA is only too aware that there are many patients who have a serious or life-threatening medical condition for which there is no available FDA-approved therapy. For such patients, one option may be to obtain … Continue reading →

Source: FDA Voice - June 22, 2016 Category: American Health Source Type: blogs